Daiichi Sankyo Stock Today
| DSKYF Stock | USD 27.90 2.29 7.59% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Daiichi Sankyo is trading at 27.90 as of the 24th of November 2024. This is a 7.59 percent decrease since the beginning of the trading day. The stock's lowest day price was 27.89. Daiichi Sankyo has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Daiichi Sankyo are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of November 2023 and ending today, the 24th of November 2024. Click here to learn more.
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company was founded in 1899 and is headquartered in Tokyo, Japan. Daiichi Sankyo operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 1.92 B outstanding shares. More on Daiichi Sankyo
Moving together with Daiichi Pink Sheet
| 0.66 | LLY | Eli Lilly Sell-off Trend | PairCorr |
| 0.65 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.74 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.7 | RHHBY | Roche Holding | PairCorr |
| 0.73 | RHHVF | Roche Holding AG | PairCorr |
Moving against Daiichi Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Daiichi Pink Sheet Highlights
| President | Hiroyuki Okuzawa |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Daiichi Sankyo [DSKYF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Large-Cap' category with a current market capitalization of 59.84 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Daiichi Sankyo's market, we take the total number of its shares issued and multiply it by Daiichi Sankyo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Daiichi Sankyo classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.92 B outstanding shares.
Daiichi Sankyo has accumulated about 807.19 B in cash with 139.23 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 421.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Daiichi Sankyo Probability Of Bankruptcy
Ownership AllocationDaiichi Sankyo holds a total of 1.92 Billion outstanding shares. Over half of Daiichi Sankyo's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Daiichi Ownership Details
Daiichi Sankyo Risk Profiles
| Mean Deviation | 5.2 | |||
| Standard Deviation | 6.3 | |||
| Variance | 39.71 | |||
| Risk Adjusted Performance | (0.04) |
Daiichi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Daiichi Sankyo without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Daiichi Sankyo Corporate Management
| Junichi Onuma | VP Department | Profile | |
| Hideyuki Haruyama | Co Adviser | Profile | |
| Akio Sakurai | Corp Unit | Profile | |
| Yoshinori Kaneshima | Corp Unit | Profile | |
| Kentaro Asakura | VP Department | Profile |
Other Information on Investing in Daiichi Pink Sheet
Daiichi Sankyo financial ratios help investors to determine whether Daiichi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Daiichi with respect to the benefits of owning Daiichi Sankyo security.